Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection

Rebecca A Rosero1, Gabriel J Villares1, Menashe Bar-Eli2

  • 1Biology Department, University of St. Thomas, Houston TX, USA.

Insights

G-protein-coupled receptors (GPCRs) are vital in cancer progression. Targeting specific GPCRs like chemokine and protease-activated receptors shows promise for treating metastatic melanoma.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • G-protein-coupled receptors (GPCRs) are integral to numerous physiological and pathological processes.
  • GPCRs influence cell proliferation and metastasis in various cancers, including melanoma.
  • Melanoma, a deadly skin cancer, has limited treatment options for metastatic stages.

Purpose of the Study:

  • To investigate the role of GPCRs in melanoma metastasis.
  • To identify specific GPCRs as potential therapeutic targets for metastatic melanoma.

Main Methods:

  • Literature review of GPCRs in cancer biology.
  • Analysis of studies focusing on chemokine receptors and protease-activated receptors in melanoma.

Main Results:

  • GPCRs significantly impact cancer cell proliferation and metastasis.
  • Chemokine receptors and protease-activated receptors are key players in the metastatic melanoma phenotype.

Conclusions:

  • Specific GPCRs, including chemokine and protease-activated receptors, are critical for melanoma metastasis.
  • These GPCRs represent promising therapeutic targets for novel anti-melanoma treatments.

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
133.8K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

6.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
7.1K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
19.3K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

2.3K